Navigation Links
Lumetra Announces Sale of Subsidiary IntegriGuard

Sale Allows Healthcare Consulting Organization to Focus on Core Business

SAN FRANCISCO, Sept. 30 /PRNewswire/ -- Lumetra, the San Francisco-based healthcare solutions consulting organization, announced today the completion of the sale of its IntegriGuard subsidiary to HMS (Nasdaq: HMSY), a publicly traded company.

In making the announcement, Linda M. Sawyer, Ph.D., RN, Lumetra's Chief Executive Officer, stated: "The sale of IntegriGuard is a significant milestone in the implementation of our strategic plan and allows Lumetra to focus on our core business and clients, driving the advancement of healthcare through evidence-based solutions and technology."

IntegriGuard was formed in 1999 as a national division of Lumetra focusing on the prevention and detection of fraud and abuse in healthcare systems. It was established as a wholly-owned subsidiary in April 2003. The sale is effective immediately.

About Lumetra

Lumetra provides reliable professional services and sustainable solutions through integrated clinical, technological, and analytic expertise to transform the delivery and administration of healthcare. For more information, please visit

SOURCE Lumetra

SOURCE Lumetra
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Lumetra Program Improves Diabetes Care Among Latinos
2. UCSF Announces Expanded Website
3. DSS Research Announces Senior Health Risk Assessment (SrHRA)(TM)
4. US Farms, Inc. Announces Distribution Partnership With Natures Best
5. Datafarm™ Announces HollisterStier Contract Manufacturing Regulatory Affairs Deploys S-Cubed eCTD
6. Hutchinson Metro Center Announces Over 50,000 SF in New Leases for Medical Space at Bronx Complex
7. President Announces Free Health Plan
8. NovoCure Ltd. announces closing of financing round
9. RCRC Independent Review Board Announces DHHS Research Oversight
10. change:healthcare Announces Twitter Application that brings Healthcare Information and Costs to Consumers' Fingertips
11. QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: